Bentham Science Logo

Track Your Manuscript:

Current Neuropharmacology

Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access


Current Neuropharmacology, Volume 13 - Number 5

The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments

, 13(5): 558 - 576

Beatrice Bortolato, Andre F. Carvalho, Joanna K. Soczynska, Giulia I. Perini and Roger S. McIntyre

DOI: 10.2174/1570159X13666150630171433

Treatment-resistant Late-life Depression: Challenges and Perspectives

, 13(5): 577 - 591

Christian Knochel, Gilberto Alves, Benedikt Friedrichs, Barbara Schneider, Anna Schmidt-Rechau, Sofia Wenzler, Angelina Schneider, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel

DOI: 10.2174/1570159X1305151013200032

Pharmacological Approaches for Treatment-resistant Bipolar Disorder

, 13(5): 592 - 604

Shi Hui Poon, Kang Sim and Ross J. Baldessarini

DOI: 10.2174/1570159X13666150630171954

From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings

, 13(5): 605 - 615

Konstantinos N. Fountoulakis, Roger S. McIntyre and Andre F. Carvalho

DOI: 10.2174/1570159X13666150630174343

Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics

, 13(5): 616 - 635

Rafael T. de Sousa, Marcus V. Zanetti, Andre R. Brunoni and Rodrigo Machado-Vieira

DOI: 10.2174/1570159X13666150630173522

Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review

, 13(5): 636 - 655

Joshua D. Rosenblat, Roger S. McIntyre, Gilberto S. Alves, Konstantinos N. Fountoulakis and Andre F. Carvalho

DOI: 10.2174/1570159X13666150630175044

Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder

, 13(5): 656 - 662

Seetal Dodd, Brisa S. Fernandes and Olivia M. Dean

DOI: 10.2174/1570159X13666150630175841

Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

, 13(5): 663 - 680

Christian Knochel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Sofia Wenzler, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel

DOI: 10.2174/1570159X13666150630173047

The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis

, 13(5): 681 - 691

Jennifer E. Thomas, Joshua Caballero and Catherine A. Harrington

DOI: 10.2174/1570159X13666150115220221

Myalgic Encephalomyelitis: Symptoms and Biomarkers

, 13(5): 701 - 734

Leonard A. Jason, Marcie L. Zinn and Mark A. Zinn

DOI: 10.2174/1570159X13666150928105725


Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook

Neurobiology of Mood Disorders

You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog